Companion Animal Medicine Market
完整報告名稱與涵蓋範圍
Companion Animal Medicine Market Size, Share & Trends Analysis Report, By Product Category (Parasiticides, Vaccines, Dermatology and Allergy Therapeutics, Pain, Osteoarthritis and Mobility Products, Chronic Disease Therapeutics (Cardiology, Endocrinology, Oncology), Antibiotics and Other Pharmaceuticals), By Animal Type (Dogs, Cats, Horses and Other Companion Animals), By Drug Modality (Small Molecules, Monoclonal Antibodies and Biologics, Vaccines and Other Biologicals), By Distribution Channel, By Region, and Segment Forecasts, 2026-2035
報告摘要
The companion animal medicine market covers prescription and veterinary-channel pharmaceuticals, biologics and vaccines for dogs, cats, horses and other companion animals, spanning parasiticides, vaccines, dermatology and allergy therapies, pain and mobility products, chronic disease therapeutics and antibiotics. Pet food, nutraceuticals, diagnostics and veterinary services are excluded.
Spending has grown with the humanisation of pets, longer animal lifespans, expansion of pet insurance and the willingness of owners to fund chronic disease management. Monoclonal antibodies for canine and feline osteoarthritis pain and atopic dermatitis have created new blockbuster categories, long-acting parasiticide combinations simplify compliance, and pipelines now include oncology, cardiology, obesity and longevity products that mirror human medicine. E-commerce and retail pharmacies are taking share from clinics for repeat medications, veterinary consolidation influences purchasing, and regulators are streamlining pathways for novel animal biologics.
North America is the largest market, Europe follows and Asia Pacific, led by China, Japan and South Korea, is growing fastest with rising pet ownership. Competition is concentrated among global animal health leaders, with specialty and biotechnology companies contributing innovative biologics.
The InsightAce study includes revenue forecasts in US$ for all product category, animal type, drug modality and distribution channel and regional segments across 2026-2035, segment-level trend analysis, competitive positioning assessment and company profiles.
授權報價
| Single User | $4,500 USD |
| Enterprise / Global Site Licence | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Companion Animal Medicine Market Snapshot
Chapter 4. Global Companion Animal Medicine Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Market Drivers
4.3. Market Challenges
4.4. Emerging Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis - Porter's Five Forces Analysis
4.7. Competitive Landscape and Market Positioning
4.8. Market Opportunity Analysis
Chapter 5. Market Segmentation 1: By Product Category Estimates & Trend Analysis
5.1. Product Category & Market Share, 2026 & 2035
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Product Category:
5.2.1. Parasiticides
5.2.2. Vaccines
5.2.3. Dermatology and Allergy Therapeutics
5.2.4. Pain, Osteoarthritis and Mobility Products
5.2.5. Chronic Disease Therapeutics (Cardiology, Endocrinology, Oncology)
5.2.6. Antibiotics and Other Pharmaceuticals
Chapter 6. Market Segmentation 2: By Animal Type Estimates & Trend Analysis
6.1. Animal Type & Market Share, 2026 & 2035
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Animal Type:
6.2.1. Dogs
6.2.2. Cats
6.2.3. Horses and Other Companion Animals
Chapter 7. Market Segmentation 3: By Drug Modality Estimates & Trend Analysis
7.1. Drug Modality & Market Share, 2026 & 2035
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Drug Modality:
7.2.1. Small Molecules
7.2.2. Monoclonal Antibodies and Biologics
7.2.3. Vaccines and Other Biologicals
Chapter 8. Market Segmentation 4: By Distribution Channel Estimates & Trend Analysis
8.1. Distribution Channel & Market Share, 2026 & 2035
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Distribution Channel:
8.2.1. Veterinary Clinics and Hospitals
8.2.2. Retail and E-Commerce Pharmacies
Chapter 9. Companion Animal Medicine Market: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. United States
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. United Kingdom
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia Pacific
9.3.1. China
9.3.2. Japan
9.3.3. India
9.3.4. South Korea
9.3.5. Australia
9.3.6. Southeast Asia
9.3.7. Rest of Asia Pacific
9.4. Latin America
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Middle East & Africa
9.5.1. GCC Countries
9.5.2. South Africa
9.5.3. Rest of Middle East & Africa
Chapter 10. Competitive Landscape
10.1. Company Market Positioning Analysis
10.2. Strategic Developments (Partnerships, Expansions, Product Launches, M&A)
Chapter 11. Company Profiles
11.1. Zoetis Inc.
11.2. Merck Animal Health (MSD Animal Health)
11.3. Boehringer Ingelheim Animal Health
11.4. Elanco Animal Health Incorporated
11.5. Ceva Sante Animale
11.6. Virbac S.A.
11.7. Dechra Pharmaceuticals PLC
11.8. Vetoquinol S.A.
11.9. Bimeda Holdings
11.10. Norbrook Laboratories Limited
11.11. Kindred Biosciences (Elanco)
11.12. Nexvet Legacy Programs (Zoetis)
11.13. Scout Bio, Inc.
11.14. Invetx (Dechra)
11.15. Jurox (Zoetis)
圖表清單 List of Tables & Figures
Table 1. Global Companion Animal Medicine Market Revenue Forecast by Product Category, 2026-2035 (US$ Mn)
Figure 1. Global Companion Animal Medicine Market Segmentation and Scope Overview
Table 2. Global Companion Animal Medicine Market Revenue Forecast by Animal Type, 2026-2035 (US$ Mn)
Figure 2. Global Companion Animal Medicine Market Share by Product Category, 2026 & 2035
Table 3. Global Companion Animal Medicine Market Revenue Forecast by Drug Modality, 2026-2035 (US$ Mn)
Figure 3. Companion Animal Medicine Growth Drivers: Pet Population, Insurance and Chronic Care Spending
Table 4. Global Companion Animal Medicine Market Revenue Forecast by Distribution Channel, 2026-2035 (US$ Mn)
Figure 4. Monoclonal Antibody and Biologic Pipeline for Dogs and Cats by Indication
Table 5. Global Companion Animal Medicine Market Revenue Forecast by Region, 2026-2035 (US$ Mn)
Figure 5. Asia Pacific Companion Animal Medicine Growth Opportunity Analysis
Table 6. North America Companion Animal Medicine Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 6. Competitive Positioning of Key Companion Animal Medicine Market Participants
Table 7. Europe Companion Animal Medicine Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 7. Porter's Five Forces Analysis of the Global Companion Animal Medicine Market
Table 8. Asia Pacific Companion Animal Medicine Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 8. Channel Shift from Veterinary Clinics to Retail and E-Commerce Pharmacies, 2026-2035
Table 9. Strategic Developments of Leading Companion Animal Medicine Market Participants, 2023-2026
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們